Elisa Frullanti

Elisa Frullanti completed a PhD in Cancer Genetics of Open University of London at the affiliated center Isitituto Nazionale Tumori (INT, Milan, Italy). She has been working in the field of lung cancer genetics for 10 years first in Milan at INT, and then at University of Siena (2013-today). In INT she conducted her research project aimed to identify functional genetic elements associated with cancer prognosis through genome wide association studies, genetic linkage and transcriptome studies winning in 2010 an AIRC Triennal Fellowship. In 2011 she won the Galilei Young Research Scientist Award Rotary International. From 2019, she will be the group leader of a research project funded by MIUR-PRIN 2017. In the last 5 years, she has introduced in her lab the use of NGS for liquid biopsy as an innovative diagnostic and prognostic technique for the early detection and the dynamical monitoring of cancer growth and resistance. She is currently Associate Professor of Genetics and Director of the Cancer Genomic and Systems Biology Lab (https://cancergenomics.unisi.it/) of the Dept. Medical Biotechnology of the University of Siena. She has extensive experience in the field of omic genetic techniques, in the next-generation sequencing of both germline, somatic and circulating DNA investigating the contribution of germline and somatic genetic variation to cancer susceptibility and outcomes. Her research activity is substantiated by more than 80 original articles in international peer-reviewed scientific journals with a total IF>500 and H-index of 28.

October 2025